News | February 22, 2010

Complimentary Atrial Fibrillation Symposium is March 13 at ACC

February 22, 2010 – The session “The Future is Now: Changing Paradigms in Atrial Fibrillation (AF) Management,” will take place 8 a.m. to noon Saturday, March 13 in Atlanta, Ga., in room A301, Georgia World Congress Center.

The complimentary symposium will address atrial fibrillation (AF) from a multifaceted, multidisciplinary approach. Participants will benefit from first-rate knowledge of the guidelines and synopses of cutting-edge developments by the world's leading experts in AF. The program will examine variations among clinicians in these settings, looking at both gaps in knowledge of and adherence to current guidelines as it relates to the future of AF care and its changing climate within the EP and cardiology community.

Participants will benefit from knowledge of the guidelines and synopses of cutting edge developments by some of the world's leading experts in AF. Areas of focus will include: anticoagulation and stroke prevention; cardioversion; heart failure in AF; appropriate selection and endpoints for anti-arrhythmic drug therapy; and patient selection and techniques surrounding catheter ablation to treat AF.

Presenters include Eric N. Prystowsky, M.D., FHRS,?The Care Group LLC; Philip B. Gorelick, M.D., MPH, University of Illinois College of Medicine at Chicago; Jonathan L. Halperin, M.D.,?Mt. Sinai Medical Center; Peter R. Kowey, M.D., FHRS,?Main Line Arrhythmia and Cardiology Consultants at Lankenau Hospital; and Francis E. Marchlinski, M.D., FHRS,?Hospital of the University of Pennsylvania

For more information:

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Overlay Init